Clinical trials in beauty products were put under the microscope on ABC's The Checkout last night, with the show highlighting the ways the industry is able to substantiate product claims.
The show looked at claims made on beauty product packages citing statistics such as “96% more firmness” and “54% less smile lines” and whether they have any scientific basis.
Only three out of a number of beauty companies contacted provided information about their process of clinical testing, with others refusing, on the basis of it including “commercially sensitive information” or “a company guarded secret”.
The show claims that the companies that did detail the methodologies used to substantiate claims came from companies such as AMA Laboratories which “deliver a unique blend of scientific research and marketing”.
The Checkout's F.U. Tube segment also picked on car dealerships and what options consumers have when if their new car turns out to be a lemon. While many dealerships might try and shirk responsibility, they're obliged to remedy for a “major failure”- but what constitutes a “major failure” is less clear.
The Checkout won 727,000 viewers across Australia's five metro areas last night, placing eighth in the free-to-air TV ratings chart, according to OzTam preliminary overnight ratings figures.
Nine News was the most-watched program, with 1.073 million viewers. Nine News at 6.30 was in second place with 1.008 million.
Seven's Home and Away was the highest ranking non-news show, winning an audience of 751,000 across Australia's five metro areas.
Nine's The Footy Show also made the top ten, with 675 000 viewers.
Completing the top 10 was Seven News/Today Tonight (third spot with 931,000 viewers), Seven News (fourth with 912,000), A Current Affair (fifth with 905,000), ABC News (sixth with 854,000) and ABC's 7.30 (ninth with 727,000).
Have something to say on this? Share your views in the comments section below. Or if you have a news story or tip-off, drop us a line at adnews@yaffa.com.au
Sign up to the AdNews newsletter, like us on Facebook or follow us on Twitter for breaking stories and campaigns throughout the day.